ArticleCancer immunology, immunotherapy : CII2024

Adding-on nivolumab to chemotherapy-stabilized patients is associated with improved survival in advanced pancreatic ductal adenocarcinoma.

Shih-Hung Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.